Stephens, Elizabeth H <br/><br/>
Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients.  [electronic resource] 

 -  Journal of the American College of Surgeons  May 2011 
 - 821-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1190 
<br/><br/><label>Standard No.: </label>10.1016/j.jamcollsurg.2011.01.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Disease Progression<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Pneumonectomy<br/>Prognosis<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Sarcoma--drug therapy<br/>Survival Rate<br/>Treatment Outcome